This Week in Women's Mental Health Another busy week. There are several interesting articles which look at non-pharmacological treatment of perinatal mood and anxiety disorders. Yoga and other complementary treatments show promise but the [...]
Obsessive compulsive disorder (OCD) may emerge during the postpartum period, either as the first onset of illness or as a recurrence of preexisting OCD. The Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-V) [...]
For women with histories of major depression, choosing whether to maintain or to discontinue treatment with an antidepressant during pregnancy is often challenging. This is a process which requires careful and thoughtful consideration, weighing the [...]
The Food and Drug Administration (FDA) has approved a new drug for the treatment of hypoactive sexual desire disorder in premenopausal women. Bremelanotide (to be marketed as Vyleesi) is used on-demand. Bremelanotide is a peptide [...]
While we have considerable information regarding the teratogenic risk associated with prenatal exposure to various antiepileptic (AED) drugs, we have less impact on exposure to AEDs on behavior outcomes in children. Several studies have shown [...]
Although there are data to support the use of many different antidepressants and other psychotropic medications, many women and their providers would prefer to avoid the use of medications during pregnancy. Options for non-pharmacologic treatment [...]
Brexanolone, to be marketed by Sage Therapeutics as Zulresso, was initially approved in March 2019, as a treatment for postpartum depression. At that time, we were told that Zulresso would be available in June 2019. [...]
We are excited to announce that we will be offering a new one day course in Women’s Mental Health in Boston on Thursday, October 17th. This is the day preceding the Annual Psychopharmacology Conference (October [...]
In our clinic, we see many women with postpartum depression. Some women know that something is wrong fairly soon after the depression sets in, and they seek help; however, far too many women present long [...]
In a large study from France (Blotière et al, 2019), researchers demonstrated that exposure to monotherapy with valproic acid was associated with 8 specific types of major congenital malformations (e.g., spina bifida, OR 19.4), and [...]